[1] |
PENG Yilun, LI Yang, WANG Xiaotao.
Study on the Mechanisms of Multiple Myeloma Cells Promoting M2 Macrophage Polarization through PI3K/AKT Signaling Pathway
[J]. Chinese General Practice, 2024, 27(08): 978-984.
|
[2] |
CHEN Qianqian, RUI Fajuan, NI Wenjing, LI Jie.
Research Progress in Epidemiology and Risk Factors of Primary Liver Cancer
[J]. Chinese General Practice, 2024, 27(06): 637-642.
|
[3] |
DONG Wendi, YANG Jiani, ZHU Jie, QUAN Yujie, ZHANG Jinjing, LIU Yan, ZHANG Hairong.
Study of Factors Associated with Concomitant Gastrointestinal Bleeding in Patients with Portal Vein Thrombosis in Liver Cirrhosis
[J]. Chinese General Practice, 2024, 27(05): 552-556.
|
[4] |
TANG Can, LI Xiangyang, LI Jing, QIN Haoran, ZHU Hong.
The Value of Nomogram Established by Serological Indicators and Tumor Diameter to Predict the Risk of Microvascular Invasion in Hepatocellular Carcinoma
[J]. Chinese General Practice, 2023, 26(36): 4514-4520.
|
[5] |
WANG Shiyue, DONG Chen, CHANG Chudi, NAN Yuemin.
Opportunities and Challenges of Surveillance for Liver Cancer in Primary Care Institutions in China
[J]. Chinese General Practice, 2023, 26(36): 4498-4504.
|
[6] |
CHENG Hao, ZHOU Jinchi, LIU Xi, KANG Lin, FAN Ahui, DOU Weijia, LIU Zhenxiong.
Risk Factors Analysis and Risk Prediction Model Establishment for Rebleeding Events within 3 Years after Endoscopic Treatment of Gastroesophageal Varices in Liver Cirrhosis Patients
[J]. Chinese General Practice, 2023, 26(35): 4446-4452.
|
[7] |
GAO Dekang, WEI Shaohua, MA Xiaoming, DU Peng, XING Chungen, CAO Chun.
Risk Factors for Loss of Skeletal Muscle Mass and Its Correlation with Complications after Major Hepatectomy for Liver Cancer
[J]. Chinese General Practice, 2023, 26(32): 4031-4037.
|
[8] |
YU Xueke, LI Mengling, PENG Siyuan, SHEN Yueming, LIANG Lunxi, ZENG Ya.
Influence of Gastroesophageal Variceal Bleeding on One-year Mortality and Associated Factors in Patients with Liver Cirrhosis
[J]. Chinese General Practice, 2023, 26(14): 1745-1752.
|
[9] |
WANG Xia, YANG Jinhui, ZHENG Mengyao, JIANG Ting, XU Zhiyuan, MA Honglin.
Advances in Diagnostic Criteria for Acute-on-chronic Liver Failure
[J]. Chinese General Practice, 2023, 26(07): 886-892.
|
[10] |
SHI Xuexiu, YUN Wenjing, WANG Haixu, ZHAO Yingying, YANG Yanan, SUN Tongwen.
Clinical Features of Hepatic Cirrhosis in Hypopituitarism
[J]. Chinese General Practice, 2023, 26(06): 699-703.
|
[11] |
GUO Dongwei, ZHANG Pengfei, REN Mingjun, LIAO Lijun, HUANG Ruyan, LUO Xiangrong.
Mechanistic of Ginkgo Biloba Extract in the Prevention and Treatment of COPD: Regulating Autophagy in Alveolar Macrophages via PI3K/Akt/mTOR Signaling Pathways
[J]. Chinese General Practice, 2023, 26(03): 293-303.
|
[12] |
CHEN Ran, YANG Haoran, SHI Huilian, LIU Qiong, TANG Ting.
Hotspots and Trends in Research on Nutrition in Cirrhosis from 1991 to 2021: a Visualized Review
[J]. Chinese General Practice, 2022, 25(32): 4091-4098.
|
[13] |
WU Fanying, LYU Wu, DU Kun, ZHOU Jingfan, HUANG Guolin, FENG Jie.
Cancer Incidence Trend in Chinese Longevity Town Cenxi City from 2016 to 2020
[J]. Chinese General Practice, 2022, 25(32): 4079-4084.
|
[14] |
Jinfa XU, Wencan SONG, Zhongxian ZHENG, Yu BAO, Gaoyan HUA, Qing CAI, Weiwei SHI, Xiufang ZHANG, Jianhua ZHANG, Zhou TONG, Guoan XIA, Fei LIU, Lintao LIU, Kesheng XIAO.
Efficacy of China-produced Camrelizumab with Apatinib for First-line Treatment in Middle and Advanced Stages of Primary Liver Cancer
[J]. Chinese General Practice, 2022, 25(26): 3258-3262.
|
[15] |
Tuoheti YAKUFU·, Kainan ZHANG, Hui ZHAO, Dawuti WUBULITALIFU·, Rui ZHANG, Renyong LIN, Guodong LYU.
Performance of Serum m3AchR-Ab for Alpha-fetoprotein-negative Hepatocellular Carcinoma Diagnosis
[J]. Chinese General Practice, 2022, 25(17): 2110-2114.
|